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Introduction
Members of the Rab family of small GTPases organize virtually 
all aspects of intracellular membrane trafficking and are highly 
enriched in neurons (Zerial and McBride, 2001; Fukuda, 2008). 
They act as membrane-bound molecular switches cycling be-
tween an inactive GDP-bound form and an active GTP-bound 
form. Rab proteins function through a set of effector proteins to 
which they bind in their active form. Through their effectors, 
Rab GTPases regulate actin and microtubule-dependent trans-
port, vesicle budding and tethering, and membrane fusion (Ng 
and Tang, 2008). Because Rab GTPases can bind to multiple 
effectors, they are able to regulate and integrate different traffick-
ing events. Through sequential interactions of a Rab GTPase 
with different downstream effectors, directionality and proof-
reading can be achieved during membrane transport. The activity 
of Rab GTPases is temporally and spatially controlled through 
the action of guanine exchange factors and GTPase-activating 
proteins (Fukuda, 2008).
Rab GTPases are prime candidates to regulate synaptic 
activity as they have been shown to control both endo- and exo-
cytosis events at the synapse (Star et al., 2005). Interestingly, a 
recent proteomic analysis of highly purified synaptic vesicles 
(SVs) revealed that a large set of other Rab GTPases can be co-
purified with SVs (Takamori et al., 2006). This suggests that 
multiple Rabs might be needed for correct SV trafficking and 
regulated release.
To find new Rab members involved in neuronal membrane 
trafficking, we analyzed the expression pattern of all Rab 
GTPases in Caenorhabditis elegans. In agreement with pre-
vious studies, we found that UNC-108, the highly conserved 
RAB-2 homologue in C. elegans, shows a very strong neuronal 
expression (Lu et al., 2008; Mangahas et al., 2008), suggesting a 
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mall guanosine triphosphatases of the Rab family 
regulate intracellular vesicular trafficking. Rab2 is 
highly expressed in the nervous system, yet its func-
tion in neurons is unknown. In Caenorhabditis elegans, 
unc-108/rab-2  mutants  have  been  isolated  based  on 
their locomotory defects. We show that the locomotion   
defects of rab-2 mutants are not caused by defects in syn-
aptic vesicle release but by defects in dense core vesicle 
(DCV) signaling. DCVs in rab-2 mutants are often en-
larged and heterogeneous in size; however, their number 
and distribution are not affected. This implicates Rab2 in 
the biogenesis of DCVs at the Golgi complex. We demon-
strate that Rab2 is required to prevent DCV cargo from 
inappropriately  entering  late  endosomal  compartments 
during DCV maturation. Finally, we show that RIC-19, the 
C. elegans orthologue of the human diabetes autoantigen 
ICA69, is also involved in DCV maturation and is recruited 
to Golgi membranes by activated RAB-2. Thus, we pro-
pose that RAB-2 and its effector RIC-19 are required for 
neuronal DCV maturation.
UNC-108/RAB-2 and its effector RIC-19 are 
involved in dense core vesicle maturation in 
Caenorhabditis elegans
Marija Sumakovic,
1 Jan Hegermann,
1 Ling Luo,
1 Steven J. Husson,
2 Katrin Schwarze,
1 Christian Olendrowitz,
1  
Liliane Schoofs,
2 Janet Richmond,
3 and Stefan Eimer
1
1European Neuroscience Institute Goettingen, German Research Foundation Research Center for Molecular Physiology of the Brain, 37077 Goettingen, Germany
2Functional Genomics and Proteomics Unit, Biology Department, Catholic University of Leuven, BE-3000 Leuven, Belgium
3Department of Biological Sciences, University of Illinois at Chicago, Chicago, IL 60607
©  2009  Sumakovic  et  al.  This  article  is  distributed  under  the  terms  of  an  Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publica-
tion date (see http://www.jcb.org/misc/terms.shtml). After six months it is available under a 
Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, 
as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
I
O
L
O
G
YJCB • VOLUME 186 • NUMBER 6 • 2009   898
(Short et al., 2001; Sinka et al., 2008). Thus, a more general 
function of Rab2 for Golgi trafficking was proposed. Therefore, 
it is surprising that C. elegans unc-108/rab-2 mutants exhibit 
very specific locomotion defects more indicative of altered sig-
naling at the neuromuscular junction (NMJ).
We report in this study that the locomotory defects of 
unc-108/rab-2 mutants result, at least in part, from altered dense 
core vesicle (DCV) signaling in neurons as the result of defects 
during DCV biogenesis. RAB-2 activity is specifically required 
for the retention of cargo in DCVs during maturation, preventing 
neuronal function. Although recent studies have focused on the 
role of UNC-108/RAB-2 in the removal of apoptotic cells (Lu 
et al., 2008; Mangahas et al., 2008) and glutamate receptor traf-
ficking (Chun et al., 2008), the precise neuronal defect impair-
ing locomotion was not investigated.
Rab2 has been shown to localize to the pre-Golgi vesicu-
lar tubular compartment and to be required for vesicular trans-
port between the ER and the Golgi apparatus (Tisdale and Balch, 
1996). Subsequently, active Rab2 was shown to also bind to 
Golgi matrix proteins and Golgi-localized coiled-coil proteins 
Figure 1.  UNC-108 is a homologue of human Rab2. (A) Sequence alignment of Rab2 from C. elegans, Homo sapiens, and Drosophila. Domains respon-
sible for phosphate and Mg
2+ binding (orange boxes) and guanine moiety binding (yellow boxes) are shown. Arrowheads indicate point mutations within 
RAB-2. Mutations rendering RAB-2 constitutively inactive (S20N) and constitutively active (Q65L) are shown (Tisdale, 1999). (B) Western blot of protein 
extracts from different unc-108 alleles probed with polyclonal RAB-2 antibodies. Tubulin loading control is also shown. (C) Quantification of normalized 
RAB-2 protein levels. Error bars = SEM (*, P < 0.05; Student’s t test; n = 4).899 RAB-2–DEPENDENT DENSE CORE VESICLE MATURATION • Sumakovic et al.
NMJs. Therefore, we tested the cholinergic signaling at NMJs by 
assaying the response of the dominant unc-108 mutants to the 
acetylcholine (ACh) esterase inhibitor aldicarb. Aldicarb prevents 
the removal of ACh from the synaptic cleft by inhibiting ACh 
esterase, leading to chronic stimulation of the postsynaptic recep-
tors, resulting in paralysis of the animal (Miller et al., 1996). n777 
and n501 mutants display a reduced sensitivity to aldicarb as 
compared with wild type (Fig. 3 B). The aldicarb resistance of 
n777 and n501 is comparable with that of rab-3 mutants, which 
its removal to endosomal compartments. We further identify 
RIC-19, the C. elegans orthologue of the human diabetes 
autoantigen ICA69, as a key RAB-2 effector for DCV matura-
tion in neuronal cell somas.
Results
UNC-108/RAB-2 mutations differentially 
affect protein function and stability
In C. elegans, UNC-108/RAB-2 is ubiquitously expressed but 
shows the strongest expression in neurons (Chun et al., 2008). 
The unc-108 gene is defined by both dominant and recessive 
alleles, which all display similar locomotory defects. The two 
dominant unc-108 alleles, n501 (D122N) and n777 (S149F), 
carry missense mutations within the conserved domains G2 and 
G3, respectively, which are required for binding of the guanine 
moiety of GTP or GDP (Fig. 1 A; Simmer et al., 2003). Reces-
sive alleles of unc-108 contain either missense mutations ce363 
(C213S) and ce365 (I11F) (Lu et al., 2008; Mangahas et al., 2008) 
or a deletion nu415 (Chun et al., 2008). The nu415 deletion 
serves as null allele, as it removes the C terminus and is not de-
tectable on Western blots. All other mutant RAB-2 proteins could 
be detected in mixed staged worm extracts by Western blotting 
using polyclonal mouse antibodies developed against C. elegans 
RAB-2 (Fig. 1 B). However, the protein levels of RAB-2 
(ce365)I11F were slightly reduced, and the amount of RAB-2 
(n777)S149F protein was strongly reduced by 80% compared 
with wild type (Fig. 1, B and C). Because all mutant RAB-2 pro-
teins were detectable in vivo, it is unlikely that differences in 
protein levels could account for the functional defects observed.
To analyze how the mutations affect RAB-2 protein func-
tion, we used recombinant GST fusion proteins to determine 
their biochemical properties, including GTP hydrolysis rates and 
GTP affinity. As a control, we used the RAB-2 mutants S20N 
(impaired in nucleotide exchange and reduced affinity for GTP) 
and Q65L (dominantly active because of a lack of GTPase activ-
ity but not GTP binding; Tisdale, 1999; Spinosa et al., 2008).
Both dominant RAB-2 mutations S149F (n777) and D122N 
(n501) affected two loops that coordinate the guanine nucleotide; 
therefore, it is likely that GTP binding was affected (Fig. 2 A). 
Although both mutations led to an increase in the affinity for GTP 
(Fig. 2 C), only the n501 mutation prevented the hydrolysis of 
GTP (Fig. 2 B). Thus, the D122N (n501) mutant RAB-2 behaves 
similar to the constitutively active Q65L mutant (Fig. 2, B and C). 
Therefore, RAB-2 n777 and n501 can be considered constitutively 
active. Thus, biochemically, n777 and n501 can be clearly distin-
guished  from  the  recessive  loss-of-function  mutation  I11F 
(ce365), which displayed wild type–like GTP affinity and hy-
drolysis rates (Fig. 2, B and C).
UNC-108/RAB-2 mutations do not affect 
SV release
unc-108(n777) and (n501) mutations cause dominant locomotory 
defects (Park and Horvitz, 1986; Simmer et al., 2003; Chun et al., 
2008), reducing locomotion in heterozygous and homozygous 
strains by 50% as compared with the wild type (Fig. 3 A). 
Impaired locomotion suggests defects in synaptic transmission at 
Figure 2.  RAB-2 mutations change the biochemical properties of the 
protein. (A) Rab2 structure with guanine-binding domain labeled in yellow. 
The altered amino acids in dominant unc-108 mutants are red. (B) GTP 
hydrolysis rates were determined in vitro using recombinant RAB-2 (n = 3 
per time point). (C) GTP affinity of recombinant RAB-2 using nonhydro-
lyzable -[
35S]GTP. Error bars = SEM (n = 9 per time point).JCB • VOLUME 186 • NUMBER 6 • 2009   900
receptors (Gally et al., 2004). We conclude that postsynaptic 
levamisole-sensitive receptors are largely unaffected by the 
dominant unc-108 mutations. To directly test whether dominant 
unc-108 mutants exhibit altered synaptic transmission, evoked 
responses were obtained from the NMJ of dissected worms. The 
mean amplitude of evoked release was not significantly different 
from wild type in either n777 or n501 (Fig. 3 D). From these data, 
we conclude that changes in cholinergic signaling are unlikely to 
account for the sluggish locomotion and aldicarb resistance of the 
dominant unc-108 mutants.
have been shown to have defects in SV tethering (Gracheva et al., 
2008). To test whether the reduced sensitivity to aldicarb is caused 
by a functional impairment of the postsynaptic site, we directly 
activated  postsynaptic ACh  receptors  by  applying  levamisole. 
The anthelmintic drug levamisole is an agonist for levamisole-
sensitive ACh receptors, leading to paralysis (Richmond and 
Jorgensen, 1999; Gally et al., 2004). unc-108 mutants displayed 
a wild type–like sensitivity to increasing concentrations of levam-
isole (Fig. 3 C) and were clearly distinguishable from the levami-
sole resistance of lev-10 mutants, which lack clustered levamisole 
Figure 3.  unc-108 mutants have reduced locomotion and aldicarb sensitivity but not SV release at the NMJ. (A) The locomotory defects of unc-108 mutants 
are synthetically enhanced in unc-108; egl-3 double mutants to the level of unc-31/CAPS. Error bars = SEM (***, P < 0.005; Student’s t test; all strains 
were compared with wild type; double mutants are compared with egl-3 and unc-31 single mutants). (B and C) Dominant unc-108 mutants are resistant to 
the ACh esterase inhibitor aldicarb (B), similar to rab-3, and exhibit a wild type–like sensitivity to the postsynaptic nicotinic receptor agonist levamisole (C). 
The weakly levamisole-resistant lev-10 mutant is shown as control. Error bars = SEM (n = 30). (D) The evoked release of SVs at the NMJ is similar between 
wild type and dominant unc-108 and ric-19 mutants. Error bars = SEM.901 RAB-2–DEPENDENT DENSE CORE VESICLE MATURATION • Sumakovic et al.
In both dominant unc-108 mutants, the YFP intensity in 
axons was strongly reduced by 65 ± 4% (n777) and 80 ± 2% 
(n501) as compared with wild type (Fig. 5 A). We obtained sim-
ilar results using the unc-108(nu415) null mutant (Fig. 5 A). 
The reduction of NLP-21–YFP fluorescence in axons can be 
rescued by expression of RAB-2 specifically in cholinergic DA 
motor neurons (unpublished data). Furthermore, the decreased 
cargo levels in axons are not restricted to NLP-21–YFP because 
tagging FLP-3 or atrial natriuretic factor neuropeptides results 
in similarly reduced YFP levels in unc-108 mutant axons (Edwards 
et al., 2009). To test whether the tagged neuropeptide cargo is 
properly secreted in unc-108 mutants, we measured the inten-
sity of the YFP fluorescence internalized by the coelomocytes 
and found that it was also decreased by 62 ± 7% for n777 and 
76 ± 2% for n501 (Fig. 5 B). Because neither unc-108 gain-of-
function mutation affected the uptake of soluble secreted GFP 
by coelomocytes (Fig. S5), the coelomocyte fluorescence inten-
sity could be used as an accurate readout for DCV exocytosis. 
Because in unc-108 mutants the NLP-21–derived YFP taken up 
by the coelomocytes is reduced to the same levels as the YFP 
content in axonal DCVs, we conclude that DCV exocytosis by 
itself is largely unaffected in unc-108/rab-2 mutants.
The reduction of synaptic NLP-21–YFP fluorescence in 
unc-108 mutants could be caused by a reduction either in the 
number or content of DCVs. To distinguish between these pos-
sibilities, we analyzed synaptic DCV number in motor neurons 
by HPF EM (Fig. 4 A). For the dominant alleles, the number of 
DCVs at the synapse was similar to wild type (Table I), and 
their distribution was unaffected (not depicted). This suggests 
that the decrease of axonal NLP-21–YFP fluorescence is specif-
ically caused by DCVs containing less NLP-21–derived YFP, 
which would be consistent with less YFP being secreted from 
motor neurons.
The loss-of-function alleles exhibited mild but variable 
reductions of DCVs number per synaptic profile, as analyzed by 
EM, ranging from 40% in ce363 to 15% in nu415 (Table I). 
However, importantly, the measured reduction of DCVs in the 
nu415 null allele was not statistically significant when com-
pared with wild type. However, the mean diameter of the DCVs 
in some of the loss- and gain-of-function alleles was slightly, 
but significantly, increased (Table I). This strongly points to an 
involvement of RAB-2 in DCV maturation.
RAB-2 localizes to the Golgi apparatus but 
not to synapses
To understand how RAB-2 affects DCV biogenesis or matura-
tion, we studied its subcellular localization. N-terminally fused 
monomeric YFP (mYFP)– or mCherry–RAB-2 localized to dis-
crete cytoplasmic puncta in cell bodies of motor neurons (Fig. 6 A). 
The localization of RAB-2 fusion proteins overlapped with gen-
eral Golgi markers such as –mannosidase II or COPI vesicles 
(Fig. 6 A). However, RAB-2 did not colocalize with makers of 
the ER (cytochrome b5) or early endosomes (FYVE domain 
of EEA-1). We also wanted to confirm the localization by ana-
lyzing the endogenous RAB-2 protein. For this purpose, we 
generated monoclonal antibodies against C. elegans RAB-2 and 
localized the endogenous RAB-2 in motor neurons on HPF   
No ultrastructural defects at the NMJ in 
unc-108 mutants
The reduced locomotion unc-108 mutants could be a conse-
quence of developmental defects or changes in the number or 
shape of synapses. However, no change in GABAergic motor 
neuron number or morphology was detected (Fig. S2 A). Fur-
thermore, by analyzing the accumulation of synaptobrevin-GFP 
(SNB-1–GFP)–labeled SVs, we showed that the synapse num-
ber, shape, and spacing of cholinergic motor neurons projecting 
axons into the dorsal cord were also comparable with wild type 
(Fig. S2 B). Therefore, it is unlikely that the behavioral defects 
in the dominant unc-108 mutants are caused by defects in motor 
neuron development or synapse formation.
To  exclude  ultrastructural  changes  at  the  synapse  of 
unc-108 mutants, we studied the morphology of presynaptic termi-
nals by high pressure freeze (HPF) EM (Rostaing et al., 2004). 
As shown in Fig. 4 A, the ultrastructure of the active zone as 
well as the size of SVs were similar to wild type for both the 
dominant and the recessive unc-108 alleles (Fig. 4 A and Table I). 
Differences in the distribution of SVs relative to the presynaptic 
density can also lead to reduced SV exocytosis and thus aldi-
carb resistance, as seen in rab-3 mutants (Gracheva et al., 2008). 
An HPF EM analysis of the SV distribution in motor neurons of 
unc-108 mutants revealed that the number and distribution of 
SVs were similar to wild type and clearly distinguishable from 
rab-3 (Fig. 4, A and B; and Table I). In addition, a precise analy-
sis of the SV distribution directly at the presynaptic density, 
distinguishing between SVs at the density versus SVs at the 
membrane, also revealed no differences between unc-108 mu-
tants and wild type (unpublished data). Furthermore, the mean 
synaptic area of cholinergic motor neurons as well as the size of 
SVs were also not affected (Table I). Therefore, we conclude 
that the ultrastructure as well as the SV distribution are un-
affected in unc-108 mutants carrying either recessive (ce363, 
ce365, and nu415) or dominant alleles (n777 and n501; Table I). 
These data are consistent with wild type–evoked responses ob-
served in all unc-108 mutants (Fig. 3 D; see Edwards et al. in 
this issue), suggesting that SV secretion is not, per se, affected 
by unc-108/rab-2 mutations.
unc-108 mutants are defective in  
DCV signaling
The  lack  of  any  detectable  defects  in  synaptic  transmission 
prompted us to investigate DCV signaling at the NMJ. In addition 
to SVs, DCVs are secreted from motor neurons. Defects in DCV 
release, like in the unc-31/CAPS mutant, can also lead to slow 
locomotion similar to unc-108 mutants (Gracheva et al., 2007). 
To analyze DCVs in unc-108 mutants, we used a strain stably 
expressing a fusion protein between the neuropeptide NLP-21 
precursor fused to YFP (NLP-21–YFP) in cholinergic motor neu-
rons. It has been previously demonstrated that NLP-21–YFP-
derived fusion proteins are packaged into DCVs, transported to 
axons, and released into the body cavity (Sieburth et al., 2007). 
Once secreted, NLP-21–derived YFP is subsequently endocytosed 
by six scavenger cells, the coelomocytes, in the body cavity. Thus, 
the level of YFP fluorescence taken up by coelomocytes can be a 
direct measure for the amount of YFP fusion protein released.JCB • VOLUME 186 • NUMBER 6 • 2009   902
Figure 4.  unc-108 mutants have normal synaptic morphology and SV distribution. (A) The morphology of motor neuron synapses in the DNC in different 
C. elegans strains is shown in 40-nm HPF EM cross sections, with electron micrographs of a single DCV section shown in the insets. (B) SV distribution 
relative to the presynaptic density was analyzed for unc-108 and ric-19 mutants, and a tethering-defective rab-3 mutant is shown as a control. unc-108 and 
ric-19 SV distributions are not significantly different compared with wild type (one way analysis of variance with Dunnett’s posttest). Error bars = SEM.903 RAB-2–DEPENDENT DENSE CORE VESICLE MATURATION • Sumakovic et al.
and (n501) mutants, by high performance liquid chromatography 
and matrix-assisted laser desorption ionization time of flight 
mass spectrometry (MALDI-TOF MS). It has been shown that 
neuropeptide processing defects can clearly be distinguished by 
this method (Husson et al., 2006, 2007a). As shown in Table S1, 
all detectable neuropeptides are correctly and fully processed in 
the dominant unc-108 mutants, including neuropeptide-like pro-
tein (NLP)–type neuropeptides, as well as the C-terminally mod-
ified FMRFamide-like peptides (FLPs; Li et al., 1999). Thus, the 
processing of neuropeptides is not defective in unc-108 mutants. 
The MALDI-TOF MS method used to analyze and detect neuro-
peptide in protein extracts from C. elegans is not quantitative 
and therefore allows only qualitative conclusions.
To test whether mutations in RAB-2 affect neuropeptide 
levels, we analyzed double mutants of unc-108/rab-2 with egl-3, 
a proprotein convertase required for proteolytically liberating 
neuropeptides from their precursor (Kass et al., 2001). In the 
absence of EGL-3 activity, no active neuropeptides were detect-
able (Husson et al., 2006). If egl-3 and unc-108 are involved in 
the same pathway required for neuropeptides, an egl-3; unc-108 
double mutant should display the same phenotype as egl-3 sin-
gle mutants. However, egl-3; unc-108 double mutants showed a 
strong enhancement of the locomotory defects, reducing loco-
motion to the level of an unc-31/CAPS mutant, which is defec-
tive in DCV release (Fig. 3 A). Both dominant and recessive 
unc-108 alleles showed the same strong synthetic interaction 
with egl-3. This suggests that unc-108 and egl-3 act in parallel 
pathways for DCV signaling. Thus, it is unlikely that unc-108 
mutations strongly affect neuropeptide signaling, which is in 
agreement with our MALDI-TOF MS analysis.
RAB-2 mutations affect DCV maturation
DCVs are generated at the late Golgi, most likely within the 
TGN (Kim et al., 2006; Morvan and Tooze, 2008). Neuro-
peptide precursors, processing enzymes, and accessory proteins 
needed for DCV exocytosis have to be sorted into transport ves-
icles that subsequently bud off the Golgi apparatus. However, 
during the sorting and packaging process, constitutive secretory 
cargo, lysosomal enzymes, and other membrane proteins are 
immuno-EM thin plastic sections. As seen in Fig. 6 B, RAB-2 
is broadly localized to the Golgi complex with some preference 
for the early Golgi cisternae. While analyzing 14 neuronal Golgi 
complexes, we found, on average, 3.3 ± 0.9 immunogold labels 
on the cis side, 1.8 ± 0.5 within the medial Golgi, and 1.1 ± 0.4 
on the trans side. However, some RAB-2 immunogold labeling 
was also seen on vesicular structures surrounding the Golgi 
(Fig. 6 B and Fig. S3 E). This RAB-2 staining was specific 
because it was absent in the nu415 deletion mutant (Fig. S3 F). 
Immunogold staining was also detectable on vesicular struc-
tures in axons; however, no specific RAB-2 staining was de-
tected on SVs or DCVs or directly at the active zone (unpublished 
data). Similarly, mCherry–RAB-2 was not detected at synapses 
of motor neurons projecting axons into the dorsal nerve cord 
(DNC) or at the synapses between the hermaphrodite-specific 
neuron (HSN) and vulva muscles (Fig. 6 C). Therefore, the 
localization data suggest that RAB-2 functions in neuronal cell 
somas, including membrane compartments at and around the 
Golgi and in axons. However, RAB-2 is not required to main-
tain the structural integrity of the Golgi because the morphol-
ogy  of  Golgi  complexes  in  dominant  or  recessive  unc-108 
mutants appeared normal when compared with wild type using 
HPF EM (Fig. S3, A–D).
Neuropeptides are processed normally in 
unc-108 mutants
The Golgi localization of RAB-2 in the cell soma and our find-
ing that unc-108 mutant DCVs have a strong deficiency in a sol-
uble cargo protein led us to investigate events related to DCV 
maturation  in  unc-108  mutants.  Neuropeptides  are  packaged 
into DCVs at the Golgi as precursors along with their processing 
enzymes,  furin  type  of  proprotein  convertases,  carboxypepti-
dases,  and  amidation  enzymes  (Husson  et  al.,  2007b). After 
cleavage from their precursor, neuropeptides are concentrated 
and aggregated within maturing DCVs. Moreover, the vesicles 
must be properly acidified to activate the processing enzymes 
(Kim et al., 2006; Morvan and Tooze, 2008). To investigate neuro-
peptide processing, we analyzed neuropeptide content in three 
independent protein extracts, from wild type and unc-108(n777) 
Table I.  SV and DCV statistics
Genotype Number of  
profiles/animals  
analyzed
Mean synaptic  
area
SV/profile Mean  
diameter of  
SVs
DCV/profile Mean  
diameter of  
DCVs
µm
2 nm nm
Wild type 30/5 0.25 ± 0.02 34.9 ± 2.4 30.3 ± 0.7 2.0 ± 0.2 44.8 ± 1.0
unc-108(n777) 34/4 0.20 ± 0.01 39.3 ± 1.8 28.4 ± 0.7 2.0 ± 0.2
a 54.1 ± 3.4
c
unc-108(n501) 31/4 0.23 ± 0.03 38.7 ± 1.7 27.7 ± 0.5 2.3 ± 0.3
a 49.4 ± 2.3
b
unc-108(ce363) 28/3 0.25 ± 0.02 35.1 ± 2.8 30.3 ± 0.7 1.2 ± 0.3
b 71.8 ± 3.4
d
unc-108(nu415) 26/4 0.21 ± 0.01 29.2 ± 1.5 26.6 ± 0.6 1.7 ± 0.4
a 46.9 ± 2.0
a
ric-19(ok833) 32/4 0.22 ± 0.01 33.1 ± 1.3 27.2 ± 0.6 2.7 ± 0.4
a 42.0 ± 2.0
a
rab-3(js49) 13/3 0.22 ± 0.02 37.7 ± 3.4 27.8 ± 0.6 3.2 ± 0.5
b 41.7 ± 1.1
b
SV and DCV numbers and diameters are as determined by HPF EM. DCV statistics of unc-108 mutants are compared with wild type (Student’s t test).
aNS.
bP < 0.05.
cP < 0.01.
dP < 0.005.JCB • VOLUME 186 • NUMBER 6 • 2009   904
Figure 5.  unc-108 mutant DCVs contain less soluble cargo. (A) Animals carrying integrated array nuIs183 are expressing NLP-21–YFP in motor neurons 
projecting axons into the DNC. Representative images of the synaptic accumulation of DCVs with YFP-tagged NLP-21 neuropeptide in the DNC in the 
respective genetic backgrounds are shown. Mean fluorescence was normalized to wild type (graph below). The absence of EGL-3 leads to strong accu-
mulation of neuropeptides at the synapse and restores wild-type levels in both dominant and recessive unc-108 alleles. Error bars = SEM (**, P < 0.01; 
***, P < 0.005; Student’s t test). (B) Once released from axons, NLP-21–derived YFP is taken up by coelomocytes. Mean coelomocyte fluorescence in vari-
ous mutants was normalized to wild type (graph below). Error bars = SEM (***, P < 0.005). (C and D) NLP-21–YFP fluorescence in motor neuron somas 
in the VNC are shown, and size distribution of NLP-21–YFP-positive vesicles in neuronal cell bodies of dominant unc-108 mutants is compared with wild 
type. Arrowheads point to vesicles with surface area >0.8 µm
2. Error bars = SEM (n = 10). Bars: (A) 10 µm; (B) 5 µm; (C) 2 µm.905 RAB-2–DEPENDENT DENSE CORE VESICLE MATURATION • Sumakovic et al.
These structures often reached sizes >0.8 µm
2, which were never 
observed in wild-type neuronal cell bodies. To determine the 
identity of these NLP-21–YFP-positive vesicular structures, we 
tested their colocalization with various subcellular markers. In 
wild-type neuronal cell bodies of the ventral nerve cord (VNC), 
most of the NLP-21–YFP overlapped with RAB-2 and the early 
endosomal marker RAB-5 (Fig. 7 A). Almost no overlap was 
seen with the late endosomal marker RAB-7 or the lysosomal 
marker LMP-1. This suggests that most of the NLP-21–derived 
YFP accumulated at the Golgi and early endosomes.
This picture changed dramatically in the dominant unc-108 
mutants, where NLP-21–YFP largely overlapped with markers 
for late endosomes and lysosomes (Fig. 7 B). This supports the 
idea that in dominant unc-108 mutants, the NLP-21–derived 
YFP is partially lost from maturing DCVs through the late 
endosomal–lysosomal degradation route. The step at which the 
copackaged into DCV precursors, forming immature DCV 
(iDCVs). To become fully functional, this inappropriate cargo 
has to be removed by clathrin-mediated membrane trafficking 
and delivered to the endosomal system. This remodeling allows 
for iDCV maturation into a mature DCV (mDCV).
In unc-108 mutants, this process is likely to be perturbed. 
Indeed, although the number of DCVs did not change in domi-
nant unc-108 mutants, the DCVs contained less NLP-21–YFP-
derived cargo. One possibility is that after the processing of the 
NLP-21–YFP fusion protein, the soluble YFP is less efficiently 
retained in iDCV and is sorted to the endosomal system during 
maturation. Therefore, one would expect to see aberrant NLP-
21–YFP accumulation in the cell bodies of unc-108 mutants. As 
shown in Fig. 5 (C and D), the neuronal cell bodies of unc-108 
mutants contained mostly large NLP-21–YFP-positive vesicular 
structures, as opposed to the small vesicles seen in wild type. 
Figure 6.  RAB-2 localizes to the Golgi apparatus and is not present at the synapses. (A) Confocal images of motor neuron cell bodies expressing fluor-
escently tagged RAB-2 along with different intracellular markers are shown. RAB-2 extensively colocalizes with the Golgi marker mannosidase II (MANS II) 
and COPI-positive structures. RAB-2 shows no or only partial colocalization with the ER (cytochrome b5) or early endosomes (FYVE domain of EEA-1). 
(B) Immunogold labeling (white circles) of endogenous RAB-2 in motor neuron cell bodies showed staining at the Golgi complex and vesicular structures 
around the Golgi. (C) mYFP–RAB-2 (red) does not accumulate at the synapses in the DNC-like mCherry–RAB-3 (green). The dashed boxes represent the 
magnified synaptic puncta demonstrating no accumulation of RAB-2 at the synapses. In HSN neurons, mCherry–RAB-2 is present only in cytoplasmic puncta 
in the neuronal cell body (closed arrowheads) but not at the synapse with vulval muscles (open arrowheads). HSN synapses are labeled by GFP–RAB-3. 
Bars: (A) 5 µm; (C) 10 µm.JCB • VOLUME 186 • NUMBER 6 • 2009   906
insulin secretion (Spitzenberger et al., 2003; Buffa et al., 2008). 
Its C. elegans orthologue, RIC-19, is exclusively expressed 
in neurons (Pilon et al., 2000). Therefore, we reasoned that 
RIC-19, like RAB-2, might also function during DCV maturation. 
Similar to unc-108 mutants, ric-19(ok833) deletion mutants dis-
played reduced locomotion and aldicarb resistance (Fig. 9,   
A and B), which could be rescued by neuronal ric-19 expression. 
This suggests that RIC-19 might be required for efficient signal-
ing at the NMJ.
Like for unc-108, both the morphology and the number 
and distribution of SVs were similar to wild type, as judged by 
EM (Fig. 4 and Table I). Consistent with this, the evoked release 
in ric-19 mutants was not significantly reduced (Fig. 3 D), sug-
gesting that SV function was normal. In contrast, ric-19(ok833) 
mutants showed a 43 ± 4% reduction in the NLP-21–YFP fluor-
escence in DNC axons (Fig. 9, C and D) as well as a corre-
sponding 46 ± 2% reduction of NLP-21–derived YFP secretion, 
as judged by coelomocyte fluorescence (Fig. 9, F and G). Both 
defects were completely rescued by neuronal expression of   
ric-19 (Fig. 9, C, D, and G). Furthermore, the appearance of 
large NLP-21–YFP-filled vesicular structures could also be seen   
in cell bodies of ric-19 mutant motor neurons, accompanied by 
the disappearance of smaller vesicular structures (Fig. S4). 
soluble YFP cargo is lost in unc-108 mutants occurs after pep-
tide processing because blocking peptide processing with a null 
mutation in the EGL-3/PC2 convertase restores wild-type levels 
of the YFP cargo in unc-108 axons (Fig. 5, A and B).
To test the hypothesis that the soluble YFP cargo is lost 
from the maturing DCV via the endosomal system, we inter-
fered with early endosomal function by expressing the GTP-
bound form RAB-5(Q78L)DA in neurons. As seen in Fig. 8   
(A and B), the YFP fluorescence levels at the synapse were spe-
cifically rescued in unc-108(n501) mutants. In contrast, expres-
sion of RAB-5(Q78L)DA in wild-type motor neurons had no 
affect on axonal levels of the NLP-21–derived YFP fluorescence. 
In agreement with this, the NLP-21–derived YFP fluorescence 
was also rescued to wild-type levels in neuronal cell bodies   
of unc-108(n501) by expression of RAB-5(Q78L)DA (Fig. 8,   
C and D). These results confirm that during DCV maturation, 
RAB-2 activity is required for retaining specific cargo in matur-
ing DCVs by preventing its entry to the late endosomal system.
RAB-2 cooperates with its effector RIC-19 
during DCV maturation
Recently, it has been shown that in insulinoma cells, the dia-
betes autoantigen ICA69 acts as a RAB-2 effector involved in   
Figure 7.  In unc-108, NLP-21–YFP enters the late endosomal compartment. (A and B) To identify NLP-21–YFP-positive vesicular structures in wild type 
(A) and unc-108(n501) strains (B) carrying the NLP-21–YFP integrated array, different intracellular markers were expressed panneuronally: RAB-2, syn-6 
(iDCVs), RAB-5 (early endosome), RAB-7 (late endosome), and LMP-1 (lysosome). The closed and open arrowheads represent larger and smaller vesicular 
structures, respectively. NLP-21–YFP-positive vesicles in the unc-108(n501) strain mostly colocalize with the early endosomal marker RAB-5. Bars, 2 µm.907 RAB-2–DEPENDENT DENSE CORE VESICLE MATURATION • Sumakovic et al.
Thus, ric-19 mutants phenocopy dominant unc-108/rab-2 mutants, 
which strongly suggests that RIC-19 and RAB-2 function in the 
same pathway required for DCV maturation.
ric-19 and unc-108 are both located on chromosome I and 
are only separated by 45 kb. Therefore, we used RNAi to show 
that unc-108 and ric-19 are in the same pathway required for 
DCV maturation. RNAi-mediated knockdown of RIC-19 by bac-
terial feeding in unc-108 mutants did not enhance the movement 
defects (Fig. 9 A) nor the loss of NLP-21–YFP fluorescence in 
the DNC axons (Fig. 9, C and D). The RIC-19 RNAi was clearly 
functional because we could reproduce the loss of NLP-21–YFP 
fluorescence in wild-type animals by RIC-19 RNAi (Fig. 9, C 
and D) and also the down-regulation of endogenous RIC-19, as 
shown by Western blotting (Fig. 9 E). This highly suggests that 
RAB-2 affects DCV maturation via RIC-19.
To determine whether RIC-19 is a direct effector of   
RAB-2, we coexpressed RIC-19 with either wild-type or GTP-
restricted (DA) or GDP-bound constitutively inactive (DN) HA-
tagged RAB-2 forms in HeLa cells and immunoprecipitated 
RAB-2 using anti-HA antibodies. RIC-19 could be specifically 
affinity purified with RAB-2(Q65L)DA and to a lesser extent 
with wild-type RAB-2 (Fig. 10 A) but not with the inactive 
form RAB-2(S20N)DN, suggesting that RIC-19 is indeed an 
effector of RAB-2.
The endogenous RIC-19 protein levels were unaffected in 
unc-108 mutants, as judged by Western blots with RIC-19 anti-
bodies (Fig. 10 B). However, the cellular localization of RIC-19 
was affected by RAB-2. Wild-type and (Q65L)DA mCherry–
RAB-2 were able to recruit RIC-19–mYFP to the Golgi in   
neuronal cell bodies (Fig. 10 C) but not RAB-2(S20N)DN. 
Particularly RAB-2(Q65L)DA was associated with a very strong 
localization of RIC-19 at the Golgi and an almost complete 
absence of the diffusely distributed pool of RIC-19 seen in 
wild-type RAB-2–expressing motor neurons. Consistently, in both 
dominant unc-108 mutants, the localization of RIC-19–mYFP 
was more confined in neuronal cell bodies as compared with 
wild type (Fig. 10 D), more strongly in n501 than in the n777 
mutant. Together, our results suggest that RAB-2 and its effec-
tor RIC-19 cooperate during DCV maturation to retain specific 
cargo in maturing DCVs and prevent its loss to the endosomal–
lysosomal system.
Discussion
Multiple roles for RAB-2 in  
membrane trafficking
C. elegans and Drosophila melanogaster Rab2 are highly   
enriched in the nervous system (Fig. S1; Zhang et al., 2007; 
Chun et al., 2008; Mangahas et al., 2008), suggesting a neuronal 
function. Accordingly, in C. elegans, dominant and recessive   
Figure  8.  Overexpression  of  constitutively  GTP-bound  RAB-5  rescues 
the DCV maturation defects of unc-108 mutants. (A and B) GTP-restricted 
RAB-5(Q78L)DA was expressed panneuronally in the NLP-21–YFP-express-
ing strain nuIs183 in wild type and unc-108 mutants. RAB-5(Q78L)DA 
expression rescues the axonal NLP-21–YFP levels in unc-108(n501) mu-
tants, whereas wild-type levels are not changed. Mean fluorescence was 
normalized to wild type. (C and D) Overexpression of RAB-5(Q78L)DA 
leads to the accumulation of NLP-21–YFP in the neuronal cell bodies in the 
VNC. (B and D) Error bars = SEM (***, P < 0.005; Student’s t test). Bars: 
(A) 10 µm; (C) 2 µm.
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Figure 9.  ric-19 mutants show similar phenotypes to unc-108 mutants. (A) ric-19 mutants show movement defects, which can be rescued by neuronal 
expression of ric-19. Knockdown of RIC-19 in unc-108 has no additional affect on locomotion. (B) ric-19(ok833) mutants are resistant to the ACh esterase 
inhibitor aldicarb, similarly to unc-108(n501). Aldicarb resistance can be rescued by neuronal expression of ric-19 (n = 30). (C and D) ric-19 deletion or 
ric-19 RNAi decreases axonal NLP-21–YFP fluorescence (nuIs183) similar to unc-108 mutants. ric-19 RNAi in unc-108 mutants shows epistasis. Neuronal 
expression of RIC-19 rescues DCV defects of ric-19 mutants. (E) Western blot showing the efficiency of RIC-19 knockdown by RNAi in unc-108(n501) 
mutants. (F and G) ric-19 mutants secrete less NLP-21–derived YFP (nuIs183), as measured by coelomocyte fluorescence, which is in agreement with the 
reduced axonal YFP levels in DCVs. This defect can be rescued by neuronal ric-19 expression. (A, B, D, and G) Error bars = SEM (**, P < 0.01; ***, 
P < 0.005; Student’s t test). Bars: (C) 10 µm; (F) 5 µm.909 RAB-2–DEPENDENT DENSE CORE VESICLE MATURATION • Sumakovic et al.
2008; Lu et al., 2008; Mangahas et al., 2008). This suggests that 
RAB-2 might be involved in several cellular processes with spe-
cific requirements for different levels of RAB-2 activity.
We  show  that  the  dominant  RAB-2  mutations  (n501) 
D122N and (n777) S149F, positioned in the conserved G2 and 
G3 domains that stabilize GTP binding (Fig. 2; Paduch et al., 
2001), biochemically behave like the engineered dominant-active 
unc-108/rab-2 mutants display locomotory defects, which are 
indicative of changes in signaling at the NMJ (Park and Horvitz, 
1986; Simmer et al., 2003; Chun et al., 2008; Lu et al., 2008; 
Mangahas et al., 2008). However, only the recessive loss-of-
function alleles are also defective in the removal of apoptotic 
cells and fluid phase endocytosis in the intestine and coelomo-
cytes as well as glutamate receptor trafficking (Chun et al., 
Figure 10.  The RAB-2 GTP-bound form recruits RIC-19 to the Golgi. (A) When expressed in HeLa cells, RIC-19 coimmunoprecipitates with wild-type (WT) 
RAB-2 and its GTP-bound RAB-2(Q65L)DA form but not its inactive GDP-bound RAB-2(S20N)DN form. As a control, the amount of affinity-purified RAB-2 is 
shown below. IP, immunoprecipitation. (B) Endogenous RIC-19 levels are not altered in unc-108 mutants, as determined by Western blotting total extracts. 
(C) RIC-19 localization is mostly cytoplasmic in cells expressing the inactive RAB-2(S20N)DN, but RIC-19 is recruited to Golgi membranes by expression of 
either wild-type RAB-2 or, to a greater extent, GTP-bound RAB-2(Q65L)DA. Arrowheads show the recruitment of RIC-19 by overexpression of GTP-restricted 
(DA) RAB-2. (D) As compared with wild-type motor neurons, RIC-19–mYFP shows increased Golgi recruitment in the dominant unc-108 mutants (marked 
by arrowheads). Bars, 4 µm.JCB • VOLUME 186 • NUMBER 6 • 2009   910
Molecular function of RAB-2 during  
DCV maturation
Rab2 has been shown to regulate vesicular transport and sorting 
at the Golgi apparatus (Chavrier et al., 1990; Tisdale and Balch, 
1996; Tisdale and Jackson, 1998; Tisdale, 1999). Consistently, 
we were not able to detect RAB-2 at synapses but found it abun-
dantly localized at neuronal Golgi complexes and on vesicular 
structures surrounding the Golgi and in axons (Fig. 6). Thus, 
RAB-2 may affect trafficking events that originate at the Golgi 
or the closely associated endosomal system. DCVs are gener-
ated at the late Golgi, most likely within the TGN (Tooze et al., 
2001; Kim et al., 2006; Morvan and Tooze, 2008). Here, neuro-
peptide precursors, processing enzymes, and accessory proteins 
needed for DCV exocytosis have to be sorted into transport con-
tainers that subsequently bud off the Golgi. Our findings that, in 
unc-108 mutants, the number of synaptic DCVs as well as the 
processing of neuropeptides are not affected make it unlikely 
that RAB-2 is required for the initial generation of iDCV. The 
fact that, in some recessive alleles, the DCV diameter is more 
variable and slightly enlarged suggests that RAB-2 might rather 
affect the fidelity of DCV maturation. In all unc-108 alleles, we 
observed DCV cargo NLP-21–YFP to colocalize more strongly 
with late endosomal and lysosomal markers as compared with 
wild-type neurons, suggesting that DCV cargo is inappropriately 
lost from maturing DCVs. Accordingly, the axonal NLP-21–YFP 
fluorescence intensity could be rescued by blocking early   
endosomal function through expression of the GTP-bound   
RAB-5(Q78L) mutant (Fig. 8). This strongly suggests that Rab2 is 
required to retain specific cargo during DCV maturation.
In addition to proneuropeptides and associated processing 
enzymes, constitutive secretory cargo, lysosomal enzymes, and 
other membrane proteins are also copackaged into DCV precur-
sors, forming iDCV budding off the Golgi. To become fully 
functional, this inappropriate cargo has to be removed from 
iDCVs by clathrin-mediated remodeling to allow maturation into 
mDCVs. This proofreading mechanism is important to ensure 
the generation of mDCVs that contain biologically active neuro-
peptides and undergo productive membrane fusion (Tooze et al., 
2001; Morvan and Tooze, 2008). In particular, after exit from 
the Golgi apparatus, iDCVs have been reported to undergo 
syn-6–dependent homotypic fusions to form a functionally distinct 
compartment from the Golgi (Wendler et al., 2001; Morvan and 
Tooze, 2008). Later on, syn-6 must be removed from iDCVs 
because it is no longer detectable on mDCVs. The cargo that is 
removed from the iDCV compartment by clathrin-coated vesi-
cles is sorted to endosomes (Morvan and Tooze, 2008). We pro-
pose that in unc-108 mutants, this sorting step is affected such 
that cargo that would normally stay in maturing DCVs, such as 
soluble cargo-like growth factors or yet unidentified GPCRs, 
are lost to the endosomal system.
Acidification has also been shown to be important for re-
tention of cargo and processed neuropeptides in maturing iDCVs. 
Neutralization  of  acidic  compartments  causes  missorting  of 
mDCV cargo and subsequent secretion from the cell (Moore et al., 
1983; Wu et al., 2001). Interestingly, a recessive unc-108 
mutation has been demonstrated to be defective in the acidifi-
cation  of  the  phagosomal  lumen,  resulting  in  engulfment   
GTP-bound RAB-2(Q65L) protein (Tisdale, 1999). In agree-
ment with this, rab-2(D122N) and rab-2(Q65L)DA are able to 
induce locomotion defects when expressed in the neurons of 
wild-type animals (Chun et al., 2008). Thus, the dominant rab-2 
alleles might still supply enough RAB-2 function for endo-
cytotic trafficking and engulfment events and might therefore 
be best suited to study the neuronal defects.
RAB-2 affects locomotion through the 
regulation of DCV signaling
An extensive HPF EM analysis showed that the synaptic morphol-
ogy as well as the SV and DCV number and distribution at the 
NMJ are unaltered in unc-108 mutants (Fig. 4). We further demon-
strated that mutations in RAB-2 specifically affect the maturation 
but not the release of DCVs. Because unc-108 mutants have im-
paired retention of soluble and transmembrane cargo during DCV 
maturation, a reasonable hypothesis is that neuropeptide function 
is impaired in unc-108 mutants, and this may cause the locomo-
tory defect. However, this seems unlikely for several reasons. First, 
the DCV maturation defect in unc-108 mutants does not affect the 
aggregated neuropeptide core of the vesicle (Fig. 4 A). Second, the 
levels of native, processed FMRFamide neuropeptides in the 
axons of unc-108 mutants are normal based on antibody staining 
(Edwards et al., 2009). This is in agreement with a MALDI-TOF 
MS analysis that showed that neuropeptide processing is not af-
fected in unc-108 mutants (Table S1). This suggests that functional 
and processing-competent DCVs are generated. Third, knocking 
out peptide processing by inactivation of the proprotein convertase 
EGL-3 in unc-108 mutants causes a strong synthetic enhancement 
of the locomotory defect indistinguishable from unc-31/CAPS 
null mutants, which lack DCV release (Fig. 3 A). This strongly 
suggests that most, if not all, neuropeptide function remains intact 
in unc-108 null mutants. Therefore, it seems likely that neuro-
peptides, once aggregated within DCVs, are retained and protected 
from loss in unc-108 mutants.
Therefore, the DCV maturation defect in unc-108 mutants 
may affect a DCV function unrelated to neuropeptides. One 
possibility is that RAB-2 affects the sorting of G protein–coupled 
receptors (GPCRs) and/or their accessory proteins needed 
for  GPCR function and specificity into DCVs (Bermak and 
Zhou, 2001). Interestingly, expression of dominant Rab2(Q65L) 
in cell culture and siRNA-mediated down-regulation of Rab2 
have been shown to both inhibit cell surface expression and 
signaling of ,-adrenergic and angiotensin II type 1 GPCRs 
(Dong and Wu, 2007). Indeed, the DCV maturation defect in 
unc-108 mutants is not restricted to soluble proteins, as the 
DCV-specific  transmembrane  protein  IDA-1/IA-2  is  also  af-
fected (Edwards et al., 2009). Another candidate for the missing 
factor would include soluble neurotrophins or growth factors 
secreted via the regulated secretory pathway.
Thus, in addition to neuropeptides yet unidentified, GPCRs 
or growth factors could be cotransported and released from 
DCVs. Because of the DCV maturation defects in unc-108 mu-
tants, one or more of these factors may be lost or excluded from 
unc-108 DCVs. Thus, we propose that the lack of DCV cargo 
caused by mistrafficking during DCV maturation results in sig-
naling defects at the NMJ, leading to reduced locomotion.911 RAB-2–DEPENDENT DENSE CORE VESICLE MATURATION • Sumakovic et al.
data strongly suggest that RIC-19 and RAB-2 act together, we 
find different requirements for RAB-2 and RIC-19 during DCV 
maturation. Whereas in unc-108 mutants the size of DCVs is 
slightly increased and more variable, it is similar to wild type in 
ric-19 mutants. This suggests that Rab2 might have additional 
functions during DCV maturation. Alternatively, RIC-19 might 
still be able to associate with iDCV membranes in the absence 
of RAB-2 via its BAR domain in a curvature-dependent mecha-
nism or through electrostatic interactions with the lipid bilayer. 
The interaction with RAB-2 might then be specifically required 
to stabilize these membrane domains to make them productive 
for sorting and the retention of cargo.
Materials and methods
Strains
If not otherwise stated, strains were grown at 20°C as described previously 
(Brenner, 1974). Strains used in this study were the wild-type Bristol N2 
strain,  unc-108(n501),  unc-108(n777),  ric-19(ok833),  rab-3(js49),  rrf-
3(pk1426), egl-3(gk238), unc-31(e928), lev-10(ok1154), arIs37 [pmyo-
3::gfp], wyIs22 [unc-86::gfp–rab-3], bIs34 [prme-8::rme-8–gfp], cdIs40 
[unc-122::gfp–cup-5], oxIs12 [punc-47::gfp], and ccIs4251; him-8(e1489). 
unc-108(ce363)  and  unc-108(ce365)  were  provided  by  K.  Miller   
(Oklahoma Medical Research Foundation, Oklahoma City, OK). KG1900 
unc-108(nu415),  nuIs152  [punc-129::gfp–snb-1],  and  nuIs183  [punc-
129::nlp-21–mvenus] were provided by J. Kaplan (Massachusetts General 
Hospital, Boston, MA).
Behavioral assays
Movement assay. To assay locomotion, animals were transferred to Nema-
tode growth medium (NGM) culture plates without food. After an initial ad-
justment period of 60 min, body bends (corresponding to a whole 360° 
sine wave) were counted over a 3-min time interval.
Drug assays. For the levamisole assay, worms were grown on NGM 
plates containing levamisole (Sigma-Aldrich) ranging in concentration from 
0 to 1 mM in the presence of food (Gally et al., 2004). After 1 h, the num-
ber of paralyzed worms was counted. Aldicarb assay was performed as 
described  previously  (Mahoney  et  al.,  2006).  Worms  were  grown  on 
plates containing 2 mM aldicarb (Sigma-Aldrich), and the number of para-
lyzed worms was monitored over a 90-min period in 10-min intervals.
Expression constructs and markers
The rab-2 gene was amplified from a cDNA library (ProQuest; Invitro-
gen),  and  the  Q65L  (dominant  active)  and  S20N  (dominant  inactive) 
mutations were introduced by site-directed mutagenesis and verified by 
sequencing. For colocalization experiments, RAB-2 was N-terminally fused 
to mCherry and expressed under the control of a 1.2-kb rab-3 promoter 
fragment. The ric-19 gene was amplified from the same cDNA library and 
C-terminally fused to YFP under the rab-3 promoter. Intracellular markers 
prab-3::gfp–cytochrome  b5,  prab-3::manosidase  II–gfp,  prab-3::2xfyve 
domain–gfp, and prab-3::rfp-cop were cloned by replacing the myo-3  
promoter from the original vector (Eimer et al., 2007). rab-3, rab-5, rab-7,   
and syn-6 cDNAs were amplified by PCR and N-terminally fused to 
mCherry  to  generate  prab-3::mCherry–rab-3,  prab-3::mCherry–rab-5, 
prab-3::mCherry–rab-7, and prab-3::mCherry–syn-6. The coding region 
of the lysosomal marker lmp-1 was amplified from genomic DNA and 
C-terminally  fused  to  mCherry,  generating  prab-3::lmp-1–mCherry.   
rab-2(S20N)DN,  rab-2(Q65L)DA,  and  rab-5(Q78L)DA  were  generated 
by site-directed mutagenesis and N-terminally fused to mCherry to gener-
ate prab-3::mCherry–rab-2(S20N)DN, prab-3::mCherry–rab-2(Q65L)DA, 
and prab-3::mCherry–rab-5(Q78L)DA.
For RNAi experiments, the entire ric-19 cDNA was cloned into the 
L4440 multiple cloning site. For rab-2 expression analysis, a 3.2-kb rab-2 
promoter fragment upstream of the start ATG was amplified from genomic 
DNA  and  subcloned  as  a  PstI  and  KpnI  fragment  into  pPD115.62  
(myo-3::gfp), replacing the myo-3 promoter. For HeLa cell expression, 
rab-2 alleles were generated via site-directed mutagenesis and cloned into 
the multiple cloning site of the pIRES2-eGFP vector (Clontech Laboratories, 
Inc.), whereas ric-19 was cloned into the pcDNA4 vector (Invitrogen). All 
constructs were verified by sequencing.
defects (Mangahas et al., 2008). However, because proprotein con-
vertases are only active under acidic pH conditions (Morvan and 
Tooze, 2008), severe defects in the acidification of iDCV would 
also lead to neuropeptide processing defects, which are not 
observed in unc-108 mutations (Table S1; Edwards et al., 2009). 
Therefore, we favor a model in which RAB-2 stabilizes membrane 
domains required for the retention of cargo in maturing DCVs.
Interestingly, Rab2, has recently been shown to bind to 
multiple Golgi-localized coiled-coil proteins (Golgins) and 
Golgi matrix proteins in a GTP-dependent manner (Short et al., 
2001; Burguete et al., 2008; Sinka et al., 2008). Golgins mark 
the identity of specific Golgi regions, whereas Golgi matrix pro-
teins  are  required  to  maintain  the  structural  integrity  of  the 
Golgi (Panic et al., 2003). The interactions of activated Rab2 
with multiple Golgins might confer retention of Rab2-labeled 
membrane domains in close proximity to the Golgi stack and 
prevent their diffusion to the cell periphery or endosomes. This 
local enrichment might also promote homotypic membrane fu-
sion and rearrangement events necessary for efficient matura-
tion  (Tooze  et  al.,  2001).  Thus,  Rab2  could  also  help  to 
orchestrate a dynamic network of functional interactions re-
quired for efficient maturation of DCVs. Because Rab2 is the 
most highly conserved Rab GTPase, its function for DCV matu-
ration is likely to be conserved throughout evolution.
RAB-2 cooperates with its effector RIC-19 
during DCV maturation
Once activated, Rab GTPases recruit effector molecules to target 
membranes. Recent work has shown that the diabetes autoanti-
gen ICA69 is a direct Rab2 effector in human insulin-producing 
 cells. Rab2 recruits ICA69 to Golgi membranes in a GTP-
dependent manner (Buffa et al., 2008). The C. elegans ICA69 or-
thologue RIC-19 is specifically expressed in neurons, and ric-19 
mutants are aldicarb resistant (Pilon et al., 2000). In this study, 
we show that ric-19 mutants display the same specific DCV mat-
uration defect observed in unc-108 mutants.
Several lines of evidence suggest that RIC-19 and ICA69 
function in a similar process during DCV maturation in cooper-
ation with Rab2. Like ICA69, RIC-19 localizes to the Golgi but 
not to vesicles (mDCVs or SVs) at the synapse (Spitzenberger 
et al., 2003). In addition, RIC-19/ICA69 is recruited to the Golgi 
by activated Rab2 through direct interaction (Spitzenberger et al., 
2003). The involvement of ICA69 in DCV maturation is also 
supported by the fact that ICA69 partially colocalizes with im-
mature secretory granules but dissociates from secretory granule 
membranes during further maturation (Spitzenberger et al., 2003).
Mechanistically, ICA69/RIC-19 might create or stabilize 
membrane domains on iDCVs during maturation through its 
BAR (Bim/amphiphysin/Rvs) domain, which is known to rec-
ognize curved membranes found on vesicles and tubular carri-
ers (Habermann, 2004; Zimmerberg and McLaughlin, 2004; 
Gallop and McMahon, 2005). Several BAR domain–containing 
homo- and heterodimeric proteins have also been shown to 
interact with Rab GTPases (Habermann, 2004). The membrane 
domains  generated  by  ICA69/RIC-19  together  with  RAB-2 
might be necessary to retain specific cargo in iDCVs and pre-
vent their missorting to the endosomal pathway. Although our JCB • VOLUME 186 • NUMBER 6 • 2009   912
Beads were washed with washing buffer (50 mM Tris-HCl, pH 7.4, 300 mM 
NaCl, 0.1% Triton X-100, 5 mM EDTA, and 0.02% Na-azide), and protein 
was eluted from the beads with SDS sample buffer and analyzed on 
SDS–polyacrylamide gels.
GTPase and GTP affinity assays
The GTPase assay was performed as previously described (Spinosa et al., 
2008). Purified proteins were dialyzed in buffer A (20 mM Tris-HCl, pH 7.8, 
100 mM NaCl, 5 mM MgCl2, 1 mM Na-phosphate, and 10 mM 2-mercapto-
ethanol) and incubated with glutathione agarose (Thermo Fisher Scientific) 
for 2 h at 4°C. Bound nucleotide was eluted washing once with buffer C 
(20 mM Tris-HCl, pH 7.8, 100 mM NaCl, 5 mM MgCl2, 1 mM Na-phosphate, 
2 mM EDTA, and 10 mM 2-mercaptoethanol) and then twice in ice-cold buf-
fer A. 1 pmol of immobilized GST-tagged proteins was then mixed with 
1 pmol -[
32P]GTP in 20 µl of buffer A and incubated at 4°C for 10 min. 50 µl 
of buffer A was added to each sample, and aliquots were taken at various 
time points. After incubation, proteins were washed three times in buffer A, 
and 8 µl of buffer B was added (0.2% SDS, 2 mM EDTA, 10 mM GDP, and 
10 mM GTP, pH 7.5). The samples were heated at 70°C, and 2-µl aliquots 
were spotted on polyethyleneimine cellulose membrane for thin-layer chro-
matography in 0.6 mM of Na-phosphate buffer, pH 3.5, and the radio-
activity spots were visualized and analyzed using ImageJ software. GTP 
affinity assay was performed as previously described (Shapiro et al., 1993). 
100 nM of GST–RAB-2 proteins was incubated with 2 µM -[
35S]GTP for 
6 h at room temperature. Subsequently, 100-fold excess of unlabeled GTP 
was added, and aliquots were collected at various time points. The bound 
radioactivity was analyzed in samples taken at the indicated time points.
EM
HPF and freeze substitution were performed as previously described (Rostaing 
et al., 2004). For morphological investigations, 50-nm sections were ana-
lyzed, and for immuno-EM, 85-nm sections were labeled (Weimer et al., 
2006) with 1:50 anti–RAB-2 mouse serum and 1:100 monoclonal anti-GFP 
antibody (Roche). Micrographs were taken with a 1,024 × 1,024–pixel 
charge-coupled device detector (Proscan CCD HSS 512/1024; Proscan 
Electronic Systems) in an electron micrograph (EM 902A; Carl Zeiss, Inc.) 
operated in the bright field mode. The SV and DCV diameter and distribu-
tion at the synapse of motor neurons were analyzed by a semiautomated 
analysis software, which is now available on our homepage.
Quantitative EM measurement and immuno-EM
The SV and DCV diameter and distribution at the synapse of motor neurons 
were analyzed by a semiautomated analysis software XtraCOunt, which is 
available on our homepage (http://www.eni.gwdg.de/index.php?id=316).   
One profile per synapse was analyzed. SVs were allocated to bins of 
50 nm extending from the presynaptic density into the cytoplasm and dis-
played as a percentage of vesicles per bin. Vesicle diameters were ana-
lyzed using the same program, but the middle of the membrane bilayer 
was used as vesicle limits.
Electrophysiology
The worm dissection was performed as previously described (Richmond et al., 
1999). In brief, animals were immobilized with cyanoacrylate glue, and 
a lateral cuticle incision was made, exposing the ventral medial body 
wall muscles. Muscle recordings were made in the whole cell voltage-clamp 
configuration (holding potential of 60 mV) using an EPC-10 patch-clamp 
amplifier (HEKA) and digitized at 1 kHz. The extracellular 340-mosM so-
lution, pH 7.3, consisted of 150 mM NaCl, 5 mM KCl, 5 mM CaCl2, 4 mM 
MgCl2, 10 mM glucose, 5 mM sucrose, and 15 mM Hepes. The patch pipette 
was filled with an 315-mosM solution, pH 7.2, of 120 mM KCl, 20 mM 
KOH, 4 mM MgCl2, 5 mM N-tris(Hydroxymethyl) methyl-2-aminoethane-
sulfonic acid, 0.25 mM CaCl2, 4 mM Na
2ATP, 36 mM sucrose, and 5 mM 
EGTA. Postsynaptic responses were evoked using a 2-ms depolarizing pulse 
delivered from a stimulating electrode placed against the VNC 100 µm 
anterior to the clamped muscle cell. Data were acquired using Pulse soft-
ware (HEKA) run on a Dell computer. Subsequent analysis and graphing 
was performed using Pulsefit (HEKA) and Igor Pro (WaveMetrics).
RNAi
RNAi by feeding was preformed as previously described (Kamath et al., 
2001). L4440 vector caring the ric-19 gene or the empty L4440 vector 
was transformed into E. coli HT115 (DE3) strain. The overnight culture, 
grown in Luria broth media with 100 µg/ml ampicillin, was used for seed-
ing NGM plates containing 50 µg/ml ampicillin and 1 mM IPTG. 10 L4 
larvae of strains with rrf-3 mutant background were transferred onto the 
Crosses and transgenic strains
Crosses were performed using classical genetic approaches, and the prog-
eny was genotyped by PCR. Table S2 lists all of the strains used and gener-
ated in this study. Transgenic strains were generated by microinjection as 
previously described (Mello et al., 1991). The injection mixes were ad-
justed to a total DNA concentration of 100 ng/µl by the addition of pBlue-
Script SKII (Agilent Technologies). Table S3 lists all of the transgenic strains 
generated for this study, including the plasmid and coinjection marker 
concentration.
Fluorescence imaging and quantitative analysis
Live animals were placed on 2% agarose pads and immobilized with 50 mM 
Na-azide in M9 buffer. All images were obtained on an inverted confocal 
microscope (SP2; Leica) using a 63× NA 1.32 oil immersion objective at 
20°C. Image stacks were captured, and maximum intensity projections 
were obtained using Confocal software (Leica).
For localization experiments, images of neuronal cell bodies in the 
VNC were taken. For the DNC experiments, images were obtained as de-
scribed previously (Sieburth et al., 2007). The posterior part of the DNC was 
imaged in young adult animals when oriented toward the objective, using the 
same settings for all of the images obtained. For the coelomocyte imaging, the 
posterior coelomocyte was imaged in young adults when oriented laterally. 
Maximum stack projections were thresholded and analyzed using ImageJ 
software (National Institutes of Health) as described previously (Sieburth et al., 
2007). For the vesicular structure diameter quantification, stacks through 
entire cells were obtained using the same magnification for all cells, and the 
diameter was determined for each vesicle observed using ImageJ software. 
The data were analyzed in ImageJ software and normalized to wild type.
Protein expression, purification, and Western blotting
The rab-2 cDNA was cloned into pGST parallel I vector (Sheffield et al., 
1999). The protein was produced in Escherichia coli BL21 star (DE3) strain 
(Invitrogen) by inducing expression with 1 mM IPTG. GST fusion proteins 
were purified by selective binding to glutathione Sepharose (GE Health-
care) according to the manufacturer’s protocol. Purified proteins were dia-
lyzed against PBS buffer. For RAB-2 and RIC-19 protein quantification, 
mixed staged worm extracts were prepared as reported previously (Eimer 
et al., 2007). Mixed staged worms were rinsed in a large (9 cm) plate 
using PBS buffer, washed four times with PBS, pelleted by centrifugation, 
and shock frozen in liquid nitrogen. The worm pellet was ground under liquid 
nitrogen to fine powder in a ceramic mortar. Before 1× SDS buffer was 
added, a 10-µl sample was used to estimate the total protein concentration 
using a Bradford assay. 15 µg of total protein extract per strain was loaded 
and separated on 15% SDS–polyacrylamide gel, blotted onto nitrocellu-
lose membrane, and probed against RAB-2 and RIC-19 (provided by 
M. Pilon, University of Gothenburg, Gothenburg, Sweden; Pilon et al., 2000) 
primary antibody using 1:2,000 and 1:5,000 dilutions, respectively, and 
peroxidase-coupled  secondary  antibodies  (The  Jackson  Laboratory).  The 
signal was revealed with Super Signal West Dura substrate (Thermo Fisher 
Scientific) and quantified using ImageJ software. The data were normalized 
to tubulin.
Antibody production
10 mice were immunized with 50 µg of purified fusion protein in PBS using 
complete Freund’s adjuvant (Sigma-Aldrich). Booster injections were given 
thereafter every 4th wk with the same amount of antigen in incomplete 
Freund’s adjuvant (Sigma-Aldrich). 30 d after the last injection, the whole 
blood was collected. To obtain polyclonal mouse antibodies against RAB-2, 
the sera were combined and affinity purified against RAB-2 fusion protein as 
reported previously (Eimer et al., 2007). Monoclonal antibodies against 
RAB-2 were generated subsequently according to standard protocols.
Cell culture
HeLa cells were grown in DME supplemented with 10% FBS, 2 mM gluta-
mine, 100 U/ml penicillin, and 10 µg/ml streptomycin in a 5% CO2 incu-
bator at 37°C. Cells were transfected in 35-mm tissue culture dishes as 
described previously (Sambrook and Russell, 2001). After 16 h, cells were 
washed in PBS, collected in PBS buffer containing 10 mM EDTA, and ex-
tracted in lysis buffer (50 mM Hepes, pH 7.4, 1% Triton X-100, 100 mM 
NaCl, 5 mM MgCl2, 1 mM PMSF, and 10 mM Na-phosphate) for 20 min at 
4°C. The protein extracts were loaded and analyzed on 15% SDS–
polyacrylamide gel. Immunoprecipitation was performed as described 
previously (Buffa et al., 2008). HA-tagged RAB-2 proteins were expressed 
in HeLa cells and upon cell lysis in lysis buffer (50 mM Tris-HCl, pH 8.0, 
150 mM NaCl, 1% Triton X-100, and 1% protease inhibitor cocktail) and 
precipitated overnight with red anti-HA affinity gel (Sigma-Aldrich) at 4°C. 913 RAB-2–DEPENDENT DENSE CORE VESICLE MATURATION • Sumakovic et al.
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Peptidomics
Endogenous peptides were extracted using a slightly modified protocol as 
previously described (Husson et al., 2005). In brief, mixed staged animals 
were extracted in ice-cold extraction solvent (methanol/water/acetic acid, 
90:9:1) and homogenized by sonification. The methanol was evaporated, 
and the aqueous solution was reextracted with ethyl acetate and n-hexane 
to remove the lipids. Finally, the peptide extract was desalted, lyophilized, 
and reconstituted in 500 µl of water containing 4% CH3CN and 0.1% 
trifluoroacetic acid (TFA) and filtered (22 µm; Ultrafree-MC; Millipore). 
Peptides were separated on a column (2.1 × 150 mm; 3.5 µm; Sym-
metry C18; Waters) using a linear gradient from 4% CH3CN in 0.1% 
aqueous TFA to 52% CH3CN in 0.1% aqueous TFA in 60 min at a flow 
rate of 300 µl/min to generate 60 fractions. The peptide content of each 
fraction was monitored by MALDI-TOF MS on an Ultraflex II instrument 
(Bruker Daltonics, GmbH).
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and unc-108 mutants. Tables S2 and S3 list the strains and transgenic arrays, 
respectively, used in this study. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200902096/DC1.
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